Allianz Se Dexcom Inc Transaction History

Allianz Se

$3.75 Trillion
Q1 2025

A detailed history of Allianz Se transactions in Dexcom Inc stock. As of the latest transaction made, Allianz Se holds 44,460 shares of DXCM stock, worth $3.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

44,460

Previous 50,216 11.46%

Holding current value

$3.69 Million

Previous $3.92 Billion 22.47%

% of portfolio

0.08%

Previous 0.1%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$67.74 - $90.75 $389,911 - $522,357	-5,756 Reduced 11.46%	44,460 $3.04 Billion
Q4 2024 Feb 12, 2025	BUY	$65.68 - $81.01 $3.3 Million - $4.07 Million	50,216 New	50,216 $3.92 Billion
Q3 2024 May 12, 2025	BUY	$64.0 - $116.06 $1.17 Million - $2.13 Million	18,356 Added 368.89%	23,332 $1.56 Billion
Q2 2024 May 12, 2025	SELL	$110.31 - $140.45 $148,697 - $189,326	-1,348 Reduced 21.32%	4,976 $564 Million
Q1 2024 May 12, 2025	SELL	$114.22 - $140.1 $4.36 Million - $5.34 Million	-38,136 Reduced 85.78%	6,324 $877 Million

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Se, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Se with notifications on news.

Account